Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study

This open‐label randomized controlled pilot study aimed to test the study feasibility of bromhexine hydrochloride (BRH) tablets for the treatment of mild or moderate coronavirus disease 2019 (COVID‐19) and to explore its clinical efficacy and safety. Patients with mild or moderate COVID‐19 were rand...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Ting, Sun, Laifang, Zhang, Wenwu, Zheng, Chanfan, Jiang, Chenchen, Chen, Mingjing, Chen, Di, Dai, Zhijuan, Bao, Shihui, Shen, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719397/
https://www.ncbi.nlm.nih.gov/pubmed/32881359
http://dx.doi.org/10.1111/cts.12881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719397/
https://www.ncbi.nlm.nih.gov/pubmed/32881359
http://dx.doi.org/10.1111/cts.12881

Ejemplares similares